Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
OtherClinical Practice Guidelines
Open Access

The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in long-distance travelers

Fahad M. Al-Hameed, Hasan M. Al-Dorzi, Mohamed A. Abdelaal, Ali Alaklabi, Ebtisam Bakhsh, Yousef A. Alomi, Mohammad Al Baik, Salah Aldahan, Holger Schünemann, Jan Brozek, Wojtek Wiercioch, Andrea J. Darzi, Reem Waziry and Elie A. Akl
Saudi Medical Journal January 2017, 38 (1) 101-107; DOI: https://doi.org/10.15537/smj.2017.1.15738
Fahad M. Al-Hameed
From the Intensive Care Department (Al-Hameed), Hematology Department (Abdelaal), College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, the Intensive Care Department (Al-Dorzi), Department of Medicine (Alaklabi), King Abdulaziz Medical City, National Guard Health Affairs, the Department of Clinical Sciences (Bakhsh), College of Medicine, Princess Nourah Bint Abdulrahman University, the General Administration of Pharmaceutical Care (Alomi), Ministry of Health, the Department of Family and Community Medicine (Al Baik, Aldahan), Prince Sultan Medical Military City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Schünemann, Brozek), the Department of Clinical Epidemiology and Biostatistics (Schünemann, Brozek, Akl), McMaster University, Hamilton, Canada, Faculty of Health Sciences (Schünemann, Brozek, Akl, Wiercioch), American University of Beirut, the Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon, and the Faculty of Medicine (Darzi, Waziry), The Kirby Institute University of New South Wales, New South Wales, Australia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Hasan M. Al-Dorzi
From the Intensive Care Department (Al-Hameed), Hematology Department (Abdelaal), College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, the Intensive Care Department (Al-Dorzi), Department of Medicine (Alaklabi), King Abdulaziz Medical City, National Guard Health Affairs, the Department of Clinical Sciences (Bakhsh), College of Medicine, Princess Nourah Bint Abdulrahman University, the General Administration of Pharmaceutical Care (Alomi), Ministry of Health, the Department of Family and Community Medicine (Al Baik, Aldahan), Prince Sultan Medical Military City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Schünemann, Brozek), the Department of Clinical Epidemiology and Biostatistics (Schünemann, Brozek, Akl), McMaster University, Hamilton, Canada, Faculty of Health Sciences (Schünemann, Brozek, Akl, Wiercioch), American University of Beirut, the Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon, and the Faculty of Medicine (Darzi, Waziry), The Kirby Institute University of New South Wales, New South Wales, Australia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamed A. Abdelaal
From the Intensive Care Department (Al-Hameed), Hematology Department (Abdelaal), College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, the Intensive Care Department (Al-Dorzi), Department of Medicine (Alaklabi), King Abdulaziz Medical City, National Guard Health Affairs, the Department of Clinical Sciences (Bakhsh), College of Medicine, Princess Nourah Bint Abdulrahman University, the General Administration of Pharmaceutical Care (Alomi), Ministry of Health, the Department of Family and Community Medicine (Al Baik, Aldahan), Prince Sultan Medical Military City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Schünemann, Brozek), the Department of Clinical Epidemiology and Biostatistics (Schünemann, Brozek, Akl), McMaster University, Hamilton, Canada, Faculty of Health Sciences (Schünemann, Brozek, Akl, Wiercioch), American University of Beirut, the Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon, and the Faculty of Medicine (Darzi, Waziry), The Kirby Institute University of New South Wales, New South Wales, Australia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ali Alaklabi
From the Intensive Care Department (Al-Hameed), Hematology Department (Abdelaal), College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, the Intensive Care Department (Al-Dorzi), Department of Medicine (Alaklabi), King Abdulaziz Medical City, National Guard Health Affairs, the Department of Clinical Sciences (Bakhsh), College of Medicine, Princess Nourah Bint Abdulrahman University, the General Administration of Pharmaceutical Care (Alomi), Ministry of Health, the Department of Family and Community Medicine (Al Baik, Aldahan), Prince Sultan Medical Military City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Schünemann, Brozek), the Department of Clinical Epidemiology and Biostatistics (Schünemann, Brozek, Akl), McMaster University, Hamilton, Canada, Faculty of Health Sciences (Schünemann, Brozek, Akl, Wiercioch), American University of Beirut, the Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon, and the Faculty of Medicine (Darzi, Waziry), The Kirby Institute University of New South Wales, New South Wales, Australia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ebtisam Bakhsh
From the Intensive Care Department (Al-Hameed), Hematology Department (Abdelaal), College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, the Intensive Care Department (Al-Dorzi), Department of Medicine (Alaklabi), King Abdulaziz Medical City, National Guard Health Affairs, the Department of Clinical Sciences (Bakhsh), College of Medicine, Princess Nourah Bint Abdulrahman University, the General Administration of Pharmaceutical Care (Alomi), Ministry of Health, the Department of Family and Community Medicine (Al Baik, Aldahan), Prince Sultan Medical Military City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Schünemann, Brozek), the Department of Clinical Epidemiology and Biostatistics (Schünemann, Brozek, Akl), McMaster University, Hamilton, Canada, Faculty of Health Sciences (Schünemann, Brozek, Akl, Wiercioch), American University of Beirut, the Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon, and the Faculty of Medicine (Darzi, Waziry), The Kirby Institute University of New South Wales, New South Wales, Australia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yousef A. Alomi
From the Intensive Care Department (Al-Hameed), Hematology Department (Abdelaal), College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, the Intensive Care Department (Al-Dorzi), Department of Medicine (Alaklabi), King Abdulaziz Medical City, National Guard Health Affairs, the Department of Clinical Sciences (Bakhsh), College of Medicine, Princess Nourah Bint Abdulrahman University, the General Administration of Pharmaceutical Care (Alomi), Ministry of Health, the Department of Family and Community Medicine (Al Baik, Aldahan), Prince Sultan Medical Military City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Schünemann, Brozek), the Department of Clinical Epidemiology and Biostatistics (Schünemann, Brozek, Akl), McMaster University, Hamilton, Canada, Faculty of Health Sciences (Schünemann, Brozek, Akl, Wiercioch), American University of Beirut, the Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon, and the Faculty of Medicine (Darzi, Waziry), The Kirby Institute University of New South Wales, New South Wales, Australia
MSc., Pharm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammad Al Baik
From the Intensive Care Department (Al-Hameed), Hematology Department (Abdelaal), College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, the Intensive Care Department (Al-Dorzi), Department of Medicine (Alaklabi), King Abdulaziz Medical City, National Guard Health Affairs, the Department of Clinical Sciences (Bakhsh), College of Medicine, Princess Nourah Bint Abdulrahman University, the General Administration of Pharmaceutical Care (Alomi), Ministry of Health, the Department of Family and Community Medicine (Al Baik, Aldahan), Prince Sultan Medical Military City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Schünemann, Brozek), the Department of Clinical Epidemiology and Biostatistics (Schünemann, Brozek, Akl), McMaster University, Hamilton, Canada, Faculty of Health Sciences (Schünemann, Brozek, Akl, Wiercioch), American University of Beirut, the Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon, and the Faculty of Medicine (Darzi, Waziry), The Kirby Institute University of New South Wales, New South Wales, Australia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salah Aldahan
From the Intensive Care Department (Al-Hameed), Hematology Department (Abdelaal), College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, the Intensive Care Department (Al-Dorzi), Department of Medicine (Alaklabi), King Abdulaziz Medical City, National Guard Health Affairs, the Department of Clinical Sciences (Bakhsh), College of Medicine, Princess Nourah Bint Abdulrahman University, the General Administration of Pharmaceutical Care (Alomi), Ministry of Health, the Department of Family and Community Medicine (Al Baik, Aldahan), Prince Sultan Medical Military City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Schünemann, Brozek), the Department of Clinical Epidemiology and Biostatistics (Schünemann, Brozek, Akl), McMaster University, Hamilton, Canada, Faculty of Health Sciences (Schünemann, Brozek, Akl, Wiercioch), American University of Beirut, the Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon, and the Faculty of Medicine (Darzi, Waziry), The Kirby Institute University of New South Wales, New South Wales, Australia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Holger Schünemann
From the Intensive Care Department (Al-Hameed), Hematology Department (Abdelaal), College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, the Intensive Care Department (Al-Dorzi), Department of Medicine (Alaklabi), King Abdulaziz Medical City, National Guard Health Affairs, the Department of Clinical Sciences (Bakhsh), College of Medicine, Princess Nourah Bint Abdulrahman University, the General Administration of Pharmaceutical Care (Alomi), Ministry of Health, the Department of Family and Community Medicine (Al Baik, Aldahan), Prince Sultan Medical Military City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Schünemann, Brozek), the Department of Clinical Epidemiology and Biostatistics (Schünemann, Brozek, Akl), McMaster University, Hamilton, Canada, Faculty of Health Sciences (Schünemann, Brozek, Akl, Wiercioch), American University of Beirut, the Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon, and the Faculty of Medicine (Darzi, Waziry), The Kirby Institute University of New South Wales, New South Wales, Australia
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Brozek
From the Intensive Care Department (Al-Hameed), Hematology Department (Abdelaal), College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, the Intensive Care Department (Al-Dorzi), Department of Medicine (Alaklabi), King Abdulaziz Medical City, National Guard Health Affairs, the Department of Clinical Sciences (Bakhsh), College of Medicine, Princess Nourah Bint Abdulrahman University, the General Administration of Pharmaceutical Care (Alomi), Ministry of Health, the Department of Family and Community Medicine (Al Baik, Aldahan), Prince Sultan Medical Military City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Schünemann, Brozek), the Department of Clinical Epidemiology and Biostatistics (Schünemann, Brozek, Akl), McMaster University, Hamilton, Canada, Faculty of Health Sciences (Schünemann, Brozek, Akl, Wiercioch), American University of Beirut, the Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon, and the Faculty of Medicine (Darzi, Waziry), The Kirby Institute University of New South Wales, New South Wales, Australia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wojtek Wiercioch
From the Intensive Care Department (Al-Hameed), Hematology Department (Abdelaal), College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, the Intensive Care Department (Al-Dorzi), Department of Medicine (Alaklabi), King Abdulaziz Medical City, National Guard Health Affairs, the Department of Clinical Sciences (Bakhsh), College of Medicine, Princess Nourah Bint Abdulrahman University, the General Administration of Pharmaceutical Care (Alomi), Ministry of Health, the Department of Family and Community Medicine (Al Baik, Aldahan), Prince Sultan Medical Military City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Schünemann, Brozek), the Department of Clinical Epidemiology and Biostatistics (Schünemann, Brozek, Akl), McMaster University, Hamilton, Canada, Faculty of Health Sciences (Schünemann, Brozek, Akl, Wiercioch), American University of Beirut, the Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon, and the Faculty of Medicine (Darzi, Waziry), The Kirby Institute University of New South Wales, New South Wales, Australia
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea J. Darzi
From the Intensive Care Department (Al-Hameed), Hematology Department (Abdelaal), College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, the Intensive Care Department (Al-Dorzi), Department of Medicine (Alaklabi), King Abdulaziz Medical City, National Guard Health Affairs, the Department of Clinical Sciences (Bakhsh), College of Medicine, Princess Nourah Bint Abdulrahman University, the General Administration of Pharmaceutical Care (Alomi), Ministry of Health, the Department of Family and Community Medicine (Al Baik, Aldahan), Prince Sultan Medical Military City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Schünemann, Brozek), the Department of Clinical Epidemiology and Biostatistics (Schünemann, Brozek, Akl), McMaster University, Hamilton, Canada, Faculty of Health Sciences (Schünemann, Brozek, Akl, Wiercioch), American University of Beirut, the Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon, and the Faculty of Medicine (Darzi, Waziry), The Kirby Institute University of New South Wales, New South Wales, Australia
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reem Waziry
From the Intensive Care Department (Al-Hameed), Hematology Department (Abdelaal), College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, the Intensive Care Department (Al-Dorzi), Department of Medicine (Alaklabi), King Abdulaziz Medical City, National Guard Health Affairs, the Department of Clinical Sciences (Bakhsh), College of Medicine, Princess Nourah Bint Abdulrahman University, the General Administration of Pharmaceutical Care (Alomi), Ministry of Health, the Department of Family and Community Medicine (Al Baik, Aldahan), Prince Sultan Medical Military City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Schünemann, Brozek), the Department of Clinical Epidemiology and Biostatistics (Schünemann, Brozek, Akl), McMaster University, Hamilton, Canada, Faculty of Health Sciences (Schünemann, Brozek, Akl, Wiercioch), American University of Beirut, the Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon, and the Faculty of Medicine (Darzi, Waziry), The Kirby Institute University of New South Wales, New South Wales, Australia
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elie A. Akl
From the Intensive Care Department (Al-Hameed), Hematology Department (Abdelaal), College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, the Intensive Care Department (Al-Dorzi), Department of Medicine (Alaklabi), King Abdulaziz Medical City, National Guard Health Affairs, the Department of Clinical Sciences (Bakhsh), College of Medicine, Princess Nourah Bint Abdulrahman University, the General Administration of Pharmaceutical Care (Alomi), Ministry of Health, the Department of Family and Community Medicine (Al Baik, Aldahan), Prince Sultan Medical Military City, Riyadh, Kingdom of Saudi Arabia, the Department of Medicine (Schünemann, Brozek), the Department of Clinical Epidemiology and Biostatistics (Schünemann, Brozek, Akl), McMaster University, Hamilton, Canada, Faculty of Health Sciences (Schünemann, Brozek, Akl, Wiercioch), American University of Beirut, the Department of Internal Medicine (Akl), American University of Beirut, Beirut, Lebanon, and the Faculty of Medicine (Darzi, Waziry), The Kirby Institute University of New South Wales, New South Wales, Australia
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

References

  1. ↵
    1. Hughes RJ,
    2. Hopkins RJ,
    3. Hill S,
    4. Weatherall M,
    5. Van de Water N,
    6. Nowitz M,
    7. et al.
    (2003) Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller’s Thrombosis (NZATT) study. Lancet 362:2039–2044.
    OpenUrlCrossRefPubMedWeb of Science
    1. Cannegieter SC,
    2. Doggen CJ,
    3. van Houwelingen HC,
    4. Rosendaal FR
    (2006) Travel-related venous thrombosis: results from a large population-based case control study (MEGA study). PLoS Med 3:e307.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Scurr JH,
    2. Machin SJ,
    3. Bailey-King S,
    4. Mackie IJ,
    5. McDonald S,
    6. Smith PD
    (2001) Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial. Lancet 357:1485–1489.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Philbrick JT,
    2. Shumate R,
    3. Siadaty MS,
    4. Becker DM
    (2007) Air travel and venous thromboembolism: a systematic review. J Gen Intern Med 22:107–114.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Lapostolle F,
    2. Surget V,
    3. Borron SW,
    4. Desmaizières M,
    5. Sordelet D,
    6. Lapandry C,
    7. et al.
    (2001) Severe pulmonary embolism associated with air travel. N Engl J Med 345:779–783.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Pérez-Rodríguez E,
    2. Jiménez D,
    3. Díaz G,
    4. Pérez-Walton I,
    5. Luque M,
    6. Guillén C,
    7. et al.
    (2003) Incidence of air travel-related pulmonary embolism at the Madrid-Barajas airport. Arch Intern Med 163:2766–2770.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Kelman CW,
    2. Kortt MA,
    3. Becker NG,
    4. Li Z,
    5. Mathews JD,
    6. Guest CS,
    7. et al.
    (2003) Deep vein thrombosis and air travel: record linkage study. BMJ 327:1072.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Parkin L,
    2. Bell ML,
    3. Herbison GP,
    4. Paul C,
    5. Skegg DC
    (2006) Air travel and fatal pulmonary embolism. Thromb Haemost 95:807–814.
    OpenUrlPubMedWeb of Science
  8. ↵
    1. Watson HG,
    2. Baglin TP
    (2011) Guidelines on travel-related venous thrombosis. Br J Haematol 152:31–34.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Kahn SR,
    2. Lim W,
    3. Dunn AS,
    4. Cushman M,
    5. Dentali F,
    6. Akl EA,
    7. et al.
    (2012) Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e195S–226S.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Kesteven P,
    2. Robinson B
    (2002) Incidence of symptomatic thrombosis in a stable population of 650,000: travel and other risk factors. Aviat Space Environ Med 73:593–596.
    OpenUrlPubMed
    1. Cannegieter SC,
    2. Doggen CJ,
    3. van Houwelingen HC,
    4. Rosendaal FR
    (2006) Travel-related venous thrombosis: results from a large population-based case control study (MEGA study). PLoS Med 3:e307.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Schwarz T,
    2. Siegert G,
    3. Oettler W,
    4. Halbritter K,
    5. Beyer J,
    6. Frommhold R,
    7. et al.
    (2003) Venous thrombosis after long-haul flights. Arch Intern Med 163:2759–2764.
    OpenUrlCrossRefPubMedWeb of Science
    1. Arfvidsson B,
    2. Eklof B,
    3. Kistner RL,
    4. Masuda EM,
    5. Sato DT
    (2000) Risk factors for venous thromboembolism following prolonged air travel. Coach class thrombosis. Hematol Oncol Clin North Am 14:391–400.
    OpenUrlCrossRefPubMedWeb of Science
    1. Martinelli I,
    2. Taioli E,
    3. Battaglioli T,
    4. Podda GM,
    5. Passamonti SM,
    6. Pedotti P,
    7. et al.
    (2003) Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives. Arch Intern Med 163:2771–2774.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Guyatt GH,
    2. Akl EA,
    3. Crowther M,
    4. Gutterman DD,
    5. Schuünemann HJ
    (2012) American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 suppl):7S–47S.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Al-Hameed F,
    2. Abdelaal MA,
    3. Alaklabi A,
    4. Aldahan S,
    5. Al-Dorzi HM,
    6. Alomi YA,
    7. et al.
    (2015) Clinical Practice Guideline on Prophylaxis of VTE in Medical Patients and Long Distance Travelers. Available from: http://www.moh.gov.sa/endepts/Proofs/Pages/Guidelines.aspx. Update 2015, Accessed 2016 July 30.
  14. ↵
    1. McMaster University Guideline Working Group
    (2014) Methodology for the Development of the Ministry of Health of Saudi Arabia and McMaster University Clinical Practice Guidelines, Available from: http://www.moh.gov.sa/endepts/Proofs/Pages/GuidelineAdaptation.aspx. Accessed 2015 February 23.
  15. ↵
    1. World Health Organization
    (2012) WHO Handbook for Guideline Development (WHO, Geneva (CH)) Available from: http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf. Cited 2014 February 7.
  16. ↵
    1. Brożek JL,
    2. Akl EA,
    3. Compalati E,
    4. Kreis J,
    5. Terracciano L,
    6. Fiocchi A,
    7. et al.
    (2011) Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy 66:588–595.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Balshem H,
    2. Helfand M,
    3. Schünemann HJ,
    4. Oxman AD,
    5. Kunz R,
    6. Brozek J,
    7. et al.
    (2011) GRADE guidelines:3. Rating the quality of evidence. J Clin Epidemiol 64:401–406.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Andrews J,
    2. Guyatt G,
    3. Oxman AD,
    4. Alderson P,
    5. Dahm P,
    6. Falck-Ytter Y,
    7. et al.
    (2013) GRADE guidelines:14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 66:719–725.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Hughes RJ,
    2. Hopkins RJ,
    3. Hill S,
    4. Weatherall M,
    5. Van de Water N,
    6. Nowitz M,
    7. et al.
    (2003) Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller’s Thrombosis (NZATT) study. Lancet 362:2039–2044.
    OpenUrlCrossRefPubMedWeb of Science
    1. Philbrick JT,
    2. Shumate R,
    3. Siadaty MS,
    4. Becker DM
    (2007) Air travel and venous thromboembolism: a systematic review. J Gen Intern Med 22:107–114.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Cesarone MR,
    2. Belcaro G,
    3. Nicolaides AN,
    4. Incandela L,
    5. De S,
    6. Geroulakos G,
    7. et al.
    (2002) Venous thrombosis from air travel: the LONFLIT3 study--prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial. Angiology 53:1–6.
    OpenUrlPubMedWeb of Science
  21. ↵
    1. Schreijer AJ,
    2. Cannegieter SC,
    3. Doggen CJ,
    4. Rosendaal FR
    (2009) The effect of flight-related behaviour on the risk of venous thrombosis after air travel. Br J Haematol 144:425–429.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. Clarke M,
    2. Hopewell S,
    3. Juszczak E,
    4. Eisinga A,
    5. Kjeldstrøm M
    (2006) Compression stockings for preventing deep vein thrombosis in airline passengers. Cochrane Database Syst Rev 2:CD004002.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Saudi Medical Journal: 38 (1)
Saudi Medical Journal
Vol. 38, Issue 1
1 Jan 2017
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in long-distance travelers
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in long-distance travelers
Fahad M. Al-Hameed, Hasan M. Al-Dorzi, Mohamed A. Abdelaal, Ali Alaklabi, Ebtisam Bakhsh, Yousef A. Alomi, Mohammad Al Baik, Salah Aldahan, Holger Schünemann, Jan Brozek, Wojtek Wiercioch, Andrea J. Darzi, Reem Waziry, Elie A. Akl
Saudi Medical Journal Jan 2017, 38 (1) 101-107; DOI: 10.15537/smj.2017.1.15738

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in long-distance travelers
Fahad M. Al-Hameed, Hasan M. Al-Dorzi, Mohamed A. Abdelaal, Ali Alaklabi, Ebtisam Bakhsh, Yousef A. Alomi, Mohammad Al Baik, Salah Aldahan, Holger Schünemann, Jan Brozek, Wojtek Wiercioch, Andrea J. Darzi, Reem Waziry, Elie A. Akl
Saudi Medical Journal Jan 2017, 38 (1) 101-107; DOI: 10.15537/smj.2017.1.15738
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Definitions
    • Summary of findings
    • Benefits and harms of the option
    • Resource use
    • Feasibility, acceptability, and equity considerations
    • Balance between desirable and undesirable consequences
    • Summary of findings
    • Benefits and harms of the option
    • Feasibility, acceptability and equity considerations
    • Balance between desirable and undesirable consequences
    • Summary of findings
    • Benefits and harms of the option
    • Feasibility, acceptability, and equity considerations
    • Balance between desirable and undesirable consequences
    • Summary of findings
    • Benefits and harms of the option
    • Resource use
    • Feasibility, acceptability, and equity considerations
    • Balance between desirable and undesirable consequences
    • Research priorities
    • Summary of findings
    • Benefits and harms of the option
    • Resource use
    • Feasibility, acceptability, and equity considerations
    • Balance between desirable and undesirable consequences
    • Discussion
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in long-distance travelers
  • Google Scholar

More in this TOC Section

  • Severe asthma in children
  • Guidelines for cochlear implantation in Saudi Arabia
  • Clinical Practice Guidelines for Liver Transplantation in Saudi Arabia
Show more Clinical Practice Guidelines

Similar Articles

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire